Investi Stratix
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
  • Politics
  • Economy
  • Forex
  • Stock
  • Editor’s Pick
No Result
View All Result
Investi Stratix
No Result
View All Result

Lionel Messi lists real estate properties as REIT

by
December 31, 2024
in Economy
0
Lionel Messi lists real estate properties as REIT

Investing.com — Argentine football star Lionel Messi has listed his real estate portfolio as a real estate investment trust (REIT) in Spain, valuing the assets at €223 million ($232 million). 

The REIT, named Edificio Rostower Socimi, includes a diversified portfolio of seven hotels, commercial real estate for shops and offices, and residential properties. 

Despite its prestigious owner, the company reported losses in both 2022 and 2023.

Rostower’s shares were priced at €57.40 on December 30 and listed on the Portfolio Stock Exchange, a smaller, digital-only Spanish bourse. 

Bloomberg noted in its article that this is an unusual choice, as most Spanish REITs opt for the more prominent BME Growth index. 

The move to establish Rostower as a REIT came swiftly after a Spanish government proposal to increase taxes on real estate trusts was blocked in parliament. 

REITs benefit from a favorable tax regime in Spain, which often incentivizes investors to list without necessarily raising funds. 

Notably, Rostower lacks free float requirements, suggesting the listing serves to meet legal prerequisites for tax advantages. However, Reuters stated that the chief executive of Portfolio Stock Exchange, Santiago Navarro, told them that the trust has told the exchange it plans to open up to new investors.

Messi’s REIT has yet to trade. Navarro reportedly informed Reuters that the exchange, launched in 2023 and overseen by the Bank of Spain, permits trading only when a company aims to sell shares or raise its capital.

 

This post appeared first on investing.com
Previous Post

China’s Xi pledges more proactive economic policies in 2025

Next Post

Drugmakers to raise US prices on over 250 medicines starting Jan. 1

Next Post
Drugmakers to raise US prices on over 250 medicines starting Jan. 1

Drugmakers to raise US prices on over 250 medicines starting Jan. 1

Subscribe to InvestiStratix.com

    Popular News

    BP’s $2.9B Azerbaijan investment fuels gas production expansion

    BP’s $2.9B Azerbaijan investment fuels gas production expansion

    June 4, 2025
    OECD cuts US outlook sharply, projects India to lead global growth: key insights

    OECD cuts US outlook sharply, projects India to lead global growth: key insights

    June 4, 2025
    How billionaire Caltagirone could influence Italy’s banking M&A wave

    How billionaire Caltagirone could influence Italy’s banking M&A wave

    June 4, 2025
    Bank of Canada set to hold rates at 2.75% as strong Q1 growth delays cuts

    Bank of Canada set to hold rates at 2.75% as strong Q1 growth delays cuts

    June 3, 2025
    Nawrocki wins Polish presidency with 50.89% vote; signals shift in EU ties

    Nawrocki wins Polish presidency with 50.89% vote; signals shift in EU ties

    June 3, 2025

    Trending News

    BP’s $2.9B Azerbaijan investment fuels gas production expansion

    BP’s $2.9B Azerbaijan investment fuels gas production expansion

    June 4, 2025
    OECD cuts US outlook sharply, projects India to lead global growth: key insights

    OECD cuts US outlook sharply, projects India to lead global growth: key insights

    June 4, 2025

    Popular News

    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      June 4, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave
      June 3, 2025

    About Us

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 investistratix.com | All Rights Reserved

    No Result
    View All Result
    • Politics
    • Economy
    • Forex
    • Stock
    • Editor’s Pick

    Copyright © 2025 investistratix.com | All Rights Reserved